High Drug Prices Could Increase Industry Innovation

Dr. Peter B. Bach is a physician at Memorial Sloan Kettering Cancer Center and the Director of its Center for Health Policy and Outcomes. He is a passionate advocate for patients and often eloquently expresses concerns on the high prices of drugs, particularly new cancer therapies. When he speaks, many people including myself pay close attention. However, his guest post on Forbes.com entitled “Could High Drug Prices Be Bad For Innovation” unfortunately is off-base.

Hey, check out all the research scientist jobs. Post your resume today!